Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2756 of 5804
-
Gum disease breakthrough? new trial tests growth factors to regrow bone
Disease control Recruiting nowThe aim of the present study is to clinically and radiographically compare the efficacy of recombinant human platelet-derived growth factor (rhPDGF), Leukocyte-Platelet Rich Fibrin (L-PRF) and Enamel Matrix Derivatives (EMD) in intrabony defects following minimally invasive non s…
Phase: NA • Sponsor: G. d'Annunzio University • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Can a tailored blood thinner dose save lives after Weight-Loss surgery?
Disease control Recruiting nowMorbid obesity, is known to be associated with a high risk of VTE and, unfortunately, fixed doses of anticoagulant regimens may not provide optimal VTE prophylaxis in these patients especially after surgery.
Phase: NA • Sponsor: Hawler Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Ultrasound zaps brain fog: new hope for long COVID sufferers?
Symptom relief Recruiting nowThis study aims to investigate whether a specific brain region mediates the cognitive deficit in long COVID brain fog, and whether targeted modulation of this region can improve cognition. In observational study, the objective was to identify potential intervention targets for p…
Phase: NA • Sponsor: Xuanwu Hospital, Beijing • Aim: Symptom relief
Last updated Jun 26, 2026 14:04 UTC
-
Same-Day chest tube removal after lung surgery: a game changer for recovery?
Symptom relief Recruiting nowThe safe conditions for early chest tube removal have been progressively questioned and redefined around reliable digital air flow criteria and extension of liquid threshold accepted. Nevertheless, in current practice, the chest tube remains in restricting early mobilization and …
Phase: NA • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
High-Tech GPS for your knee: new navigation system aims to improve joint replacement
Symptom relief OngoingEvaluation of a new navigation system in computer-assisted total knee arthroplasty.
Phase: NA • Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Electrical fingerprints may reveal hidden scarring in cochlear implant patients
Knowledge-focused CompletedCochlear fibrosis development can compromise the success and the outcomes of the cochlear implantation (CI) thus affecting the quality of life of the implanted patient. Correlating the results of the Transimpedance Matrix (TIM) measurements to the implant electrode location deter…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
Ear-Zap therapy could spare kids from steroid side effects
Disease control Recruiting nowChildren with frequently relapsing nephrotic syndrome (FRNS) are exposed to prolonged courses of steroids and other immunosuppressant medications. Given the adverse side effect profiles and variable efficacy of these medications, there is an urgent need to identify novel and safe…
Phase: NA • Sponsor: Northwell Health • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Pregnancy diet study checks Kids' health 12 years later
Knowledge-focused CompletedThe participant (both mother and child) in the initial TOP study will be invited to a follow-up study to evaluate the effect of life style intervention during pregnancy on both mother and their offspring 12 years after the intervention. The study will contribute to understanding …
Phase: NA • Sponsor: Steno Diabetes Center Copenhagen • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Light at home may lift brain fog for childhood cancer survivors
Symptom relief OngoingSurvivors of childhood cancer are at greater risk for long-term cognitive impairments that include attention, executive function, intelligence, memory, and processing speed. The participants are a survivor of acute lymphoblastic leukemia (ALL) or Hodgkin's lymphoma (HL). Because …
Phase: NA • Sponsor: St. Jude Children's Research Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Sickle cell drug safety trial ends early
Disease control TerminatedAn Open-label Extension Study of GBT021601 in Participants with Sickle Cell Disease
Phase: PHASE2, PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New Immune-Boosting drug takes on tough cancers in first human trial
Disease control OngoingThis is a phase I, First-in-Human (FIH), open-label study to evaluate the safety, tolerability, pharmacokinetic (PK) profile, and preliminary efficacy of AB248 as monotherapy OR in combination with pembrolizumab in adult participants with locally advanced or metastatic solid tumo…
Phase: PHASE1 • Sponsor: Asher Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 26, 2026 15:50 UTC
-
Scientists hunt for hidden triggers of autoimmune diseases
Knowledge-focused Recruiting nowThe most clinically meaningful way to discover new targets of T cells in autoimmune diseases is to study the tissues of patients with active autoimmune disease mediated organ inflammation. These tissues contain both cytotoxic and helper T cells that are driving their disease, and…
Sponsor: TScan Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Could probiotic capsules beat bacterial vaginosis?
Disease control CompletedThis is a multicenter, randomized, double-blind, placebo-controlled phase IIb clinical study, to evaluate the efficacy and safety of the dual - live Lactobacilli-containing vaginal capsule for the treatment of bacterial vaginosis.
Phase: PHASE2 • Sponsor: Guangdong Longchuangji Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New pneumonia vaccine shows promise in early trial
⭐️ VACCINE ⭐️ CompletedThis study is an open-label combined randomized double-blind, positive control phase Ⅰ clinical trial of the a 13-valent Pneumococcal Polysaccharide Conjugate Vaccine manufactured by Sinovac Research \& Development Co., Ltd. The purpose of this study is to preliminary evaluate th…
Phase: PHASE1 • Sponsor: Sinovac Life Sciences Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:00 UTC
-
New allograft injection could thaw frozen shoulders better than steroids
Symptom relief CompletedThe purpose of this study is to compare ActiveMatrix® to standard of care corticosteroid injection in the treatment of adhesive capsulitis of the shoulder (frozen shoulder).
Phase: PHASE4 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Symptom relief
Last updated Jun 27, 2026 09:11 UTC
-
New drug offers hope for chronic stomach pain and nausea
Symptom relief CompletedThis is a double-blind, randomized, multicenter, placebo-controlled, comparative phase II dose-finding trial. The trial will be conducted with four treatment groups in the form of a parallel group comparison and will serve to compare oral treatment with daily doses of 10, 20, or …
Phase: PHASE2 • Sponsor: Dr. Falk Pharma GmbH • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Herbal granule shows promise in easing kidney harm from cancer drugs
Symptom relief CompletedThis is a prospective, single-arm, single-center, exploratory study. The purpose of this study is to explore the effect of Huaier Granule on nephrotoxicity associated with anti-angiogenesis targeted therapy for advanced hepatobiliary malignancies.
Phase: PHASE2 • Sponsor: Fudan University • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
New hope for tough cancers: experimental drug LP-284 enters human testing
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the safety and tolerability of escalating doses of LP-284 and to determine the maximum tolerated dose (MTD) and the recommended Phase 2 dose (RP2D) in patients with relapsed or refractory (R/R) lymphomas and solid tumors. The seconda…
Phase: PHASE1 • Sponsor: Lantern Pharma Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Daily exercise may ease radiation side effects for head and neck cancer patients
Symptom relief Recruiting nowThe study includes patients with tumors of the oropharynx, larynx and hypopharynx scheduled to receive radiotherapy with curative intent (+/- chemotherapy). The patients will be randomized into either an intervention group (performing a preventive physical activity protocol befor…
Phase: NA • Sponsor: Sahlgrenska University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Scientists seek clues to predict weight loss success after new stomach procedure
Knowledge-focused CompletedWeight loss is of paramount importance to ameliorate obesity-related complications. Endoscopic sleeve gastroplasty is a new therapeutic option to obtain significant weight reduction in obese patients. Nevertheless, a only a part of patients experience sufficient weight loss to im…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC